A Phase III Randomized Trial of Radiotherapy Optimization for Low-Risk HER2-positive Breast Cancer (HERO): NRG-BR008.
Lior Braunstein,Melissa Mitchell,Hanna Bandos,William Sikov,Atif Khan,Peter Chen,Patricia Ganz,Reshma Jagsi,Julia White,Reena Cecchini,Hyejoo Kang,Shannon Puhalla,Kelly Bolton,Eileen Connolly,Erica Stringer-Reasor,Kimberly Gergelis,Thomas Julian,Eleftherios Mamounas,Norman Wolmark CANCER RESEARCH（2024）
AI 理解论文
溯源树
样例
